Acquired by PHOENIX in Jun 2024
EXPR - Express, Inc.
NYSE
->
Consumer Cyclical
->
Apparel Retail
Columbus,
United States
Type: Equity
EXPR price evolution
EXPR
| (in millions $) | 30 Oct 2024 | 28 Nov 2023 | 29 Aug 2023 | 29 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $34.64 | $58.58 | ||
| Short term investments | ||||
| Net receivables | $34.58 | $20.6 | $18.25 | |
| Inventory | $480.87 | $415.8 | $346.96 | |
| Total current assets | $598.88 | $556.9 | $477.84 | |
| Long term investments | $166.21 | $166.21 | ||
| Property, plant & equipment | $651.19 | $669.8 | $651.03 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $868.88 | $895.18 | ||
| Total investments | $166.21 | $166.21 | ||
| Total assets | $1467.76 | $1452 | $1353.7 | |
| Current liabilities | ||||
| Accounts payable | $263.22 | $232.4 | $162.37 | |
| Deferred revenue | $43.23 | $48.72 | ||
| Short long term debt | $193.46 | $191.55 | ||
| Total current liabilities | $613.07 | $596.3 | $510.21 | |
| Long term debt | $270.51 | $220.8 | $179.75 | |
| Total noncurrent liabilities | $706.74 | $669.8 | ||
| Total debt | $881.56 | $841.86 | ||
| Total liabilities | $1319.8 | $1266.1 | $1118.04 | |
| Shareholders' equity | ||||
| Retained earnings | $185.12 | $222.4 | $269.81 | |
| Other shareholder equity | $235.66 | |||
| Total shareholder equity | $147.96 | $185.92 | ||
| (in millions $) | 28 Feb 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $65.61 | $41.18 | $55.87 | $207.14 |
| Short term investments | ||||
| Net receivables | $13.84 | $11.74 | $14.56 | $10.82 |
| Inventory | $365.65 | $358.8 | $264.36 | $220.3 |
| Total current assets | $534.4 | $490.74 | $474.51 | $470.69 |
| Long term investments | $166.11 | |||
| Property, plant & equipment | $638.73 | $763.44 | $977.98 | $1258.55 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $863.92 | $768.72 | $983.95 | $1320.05 |
| Total investments | $166.11 | |||
| Total assets | $1398.33 | $1259.45 | $1458.46 | $1790.74 |
| Current liabilities | ||||
| Accounts payable | $191.39 | $231.97 | $150.23 | $126.86 |
| Deferred revenue | $55.4 | $35.98 | $32.43 | $38.23 |
| Short long term debt | $189.01 | $207.84 | $203.44 | $226.17 |
| Total current liabilities | $541.59 | $586.65 | $515.05 | $467.48 |
| Long term debt | $122 | $654.49 | $914.98 | $897.3 |
| Total noncurrent liabilities | $549.17 | $671.49 | $933.72 | $916.96 |
| Total debt | $717.45 | $862.33 | $1118.42 | $1123.48 |
| Total liabilities | $1090.76 | $1258.15 | $1448.77 | $1384.44 |
| Shareholders' equity | ||||
| Retained earnings | $355.74 | $77.09 | $114.73 | $533.69 |
| Other shareholder equity | $307.57 | $1.31 | -$0.12 | $0.47 |
| Total shareholder equity | $307.57 | $1.31 | $9.69 | $406.3 |
| (in millions $) | 30 Oct 2024 | 28 Nov 2023 | 29 Aug 2023 | 29 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $454.06 | $435.3 | $383.26 | |
| Cost of revenue | ||||
| Gross Profit | $109.52 | $104.1 | $63.79 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $143.65 | $139.5 | $138.35 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1.9 | $0.6 | $0.37 | |
| Interest expense | -$0.78 | $2.3 | -$2.94 | |
| Net income | ||||
| Net income | -$36.81 | -$44.1 | -$73.43 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2022 | 1 Mar 2022 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1864.18 | $1208.37 | $2019.19 | |
| Cost of revenue | $1335.59 | $1213.28 | $1468.62 | |
| Gross Profit | $528.59 | -$4.91 | $550.58 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $596.67 | $450.83 | $564.33 | |
| Total operating expenses | $596.08 | $450.31 | $768.44 | |
| Operating income | -$67.49 | -$455.21 | -$217.87 | |
| Income from continuing operations | ||||
| EBIT | $343.39 | -$457.95 | -$217.87 | |
| Income tax expense | $20.45 | -$55.9 | -$50.53 | |
| Interest expense | $29.1 | $3.4 | -$2.98 | |
| Net income | ||||
| Net income | $293.83 | -$405.45 | -$164.36 | |
| Income (for common shares) | $293.83 | -$405.45 | -$164.36 | |
| (in millions $) | 28 Nov 2023 | 29 Aug 2023 | 29 May 2023 | 28 Feb 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$51.69 | -$44.6 | -$8.3 | $196.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $152.09 | $98.4 | $57.4 | -$14.5 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$30.97 | -$7 | -$31.52 | $24.44 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | $293.83 | -$14.44 | -$405.45 | -$164.36 |
| Operating activities | ||||
| Depreciation | $62.17 | $67.62 | $73.7 | $85.38 |
| Business acquisitions & disposals | $243.39 | |||
| Stock-based compensation | $7.54 | $9.81 | $9.46 | $8.18 |
| Total cash flows from operations | -$157.08 | $89.38 | -$323.63 | $90.71 |
| Investing activities | ||||
| Capital expenditures | -$47.38 | -$34.77 | -$16.85 | -$37.04 |
| Investments | ||||
| Total cash flows from investing | $196.01 | -$34.77 | -$16.85 | -$37.04 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.9 | -$15.61 | ||
| Net borrowings | -$9.74 | -$65.08 | $196.82 | -$0.09 |
| Total cash flows from financing | -$14.5 | -$69.31 | $189.22 | -$18.2 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $24.44 | -$14.7 | -$151.26 | $35.47 |
News
|
PetMed Express, Inc. (PETS): A Bear Case Theory
Insider Monkey · via Yahoo Finance
30 Nov 2024
|
|
What To Expect From PetMed Express Inc (PETS) Q2 2025 Earnings
GuruFocus.com · via Yahoo Finance
5 Nov 2024
|
|
PetMed Express, Inc. (PETS): A Bull Case Theory
Insider Monkey · via Yahoo Finance
24 Oct 2024
|
|
Evercore ISI downgrades Caribou Biosciences stock amid strategic challenges By Investing.com
Investing.com
3 Jun 2024
|
|
Why Is XChange Tec.Inc (XHG) Stock Up 97% Today?
InvestorPlace
31 May 2024
|
|
MongoDB stock plummets 20% on weak guidance By Investing.com
Investing.com
30 May 2024
|
|
Alphabet Inc. (GOOG) Stock Moves -0.35%: What You Should Know
Zacks via Yahoo Finance
29 May 2024
|
|
Favourable Signals For PetMed Express: Numerous Insiders Acquired Stock
Simply Wall St. via Yahoo Finance
10 May 2024
|
|
Simon Sells ABG Stake, Eyes Express Despite Cooling Retail Holdings
Forbes
10 May 2024
|
|
Insider Buying Alert: CEOs Are Buying These 10 Stocks
Insider Monkey via Yahoo Finance
9 May 2024
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 3.55 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |